4,020 Shares in SPDR S&P Biotech ETF $XBI Acquired by Apella Capital LLC

Apella Capital LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 4,020 shares of the exchange traded fund’s stock, valued at approximately $490,000.

Other large investors have also made changes to their positions in the company. Compass Wealth Management LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $1,167,000. China Universal Asset Management Co. Ltd. boosted its position in shares of SPDR S&P Biotech ETF by 868.3% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 4,919 shares of the exchange traded fund’s stock worth $493,000 after acquiring an additional 4,411 shares in the last quarter. Ashton Thomas Private Wealth LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $417,000. Altfest L J & Co. Inc. boosted its position in shares of SPDR S&P Biotech ETF by 63.1% during the 3rd quarter. Altfest L J & Co. Inc. now owns 124,921 shares of the exchange traded fund’s stock worth $12,517,000 after acquiring an additional 48,326 shares in the last quarter. Finally, Brian Low Financial Group LLC acquired a new stake in shares of SPDR S&P Biotech ETF during the 3rd quarter worth approximately $668,000.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $130.65 on Thursday. The company has a market cap of $7.96 billion, a price-to-earnings ratio of 11.47 and a beta of 0.91. The firm has a 50 day simple moving average of $125.11 and a 200 day simple moving average of $119.10. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $133.27.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.